The Journal of Neuroscience, October 18, 2006, 26(42):10621-10622; doi:10.1523/JNEUROSCI.3599-06.2006
Previous Article | Next Article 
Journal Club
Editor's Note: These short reviews of a recent paper in the Journal, written exclusively by graduate students or postdoctoral fellows, are intended to mimic the journal clubs that exist in your own departments or institutions. For more information on the format and purpose of the Journal Club, please see http://www.jneurosci.org/misc/ifa_features.shtml.
Novel Probes for G-Protein-Coupled Receptor Signaling
Jill B. Jensen1 and
Jane E. Lauckner1,2
1Department of Physiology and Biophysics and 2Neurobiology and Behavior Graduate Program, University of Washington School of Medicine, Seattle, Washington 98195
Review of Robbins et al. (http://www.jneurosci.org/cgi/content/full/26/30/7950)
G-protein-coupled receptors (GPCRs) constitute the largest known protein family. They are activated by a wide range of ligands to transduce an extracellular signal into an intracellular one that evokes a variety of physiological responses, including regulation of ion channels by neurotransmitters and hormones. One such example is modulation of M-type potassium current by Gq/11 G-proteins. This plays an important role in regulating neuronal excitability. M current is encoded by Kv7.2 (KCNQ2) and Kv7.3 (KCNQ3) channel subunits. Multiple mutations in these subunits cause neuronal hyperexcitability and underlie a mild epileptic syndrome, benign familial neonatal convulsions. The membrane phospholipid phosphatidylinositol-4,5-bisphosphate (PIP2) is the principal determinant of M current activity, and its cleavage on activation of Gq/11 G-proteins underlies channel closure and slow membrane depolarization (Fig. 1). Many ion channels are modulated by PIP2, including voltage-gated calcium channels, inward rectifier potassium channels, and some transient receptor potential ion channels (Suh and Hille, 2005
). Given our increasing understanding of the role of G-proteins and PIP2 in cellular signaling, it is important to develop tools to examine GPCRG-protein and PIP2channel interactions.
Several approaches have been used to study GPCR-mediated pathways. The more successful of these involve selectively attenuating the function of candidate signaling molecules and determining how this affects the end result of GPCR activation. One such technique is the use of anti-G-protein antibodies. The antibodies inhibit GPCR signaling (Caulfield et al., 1994
) but can lack specificity, are slow acting and irreversible, and are difficult to use in intact cells. Another approach has been to use dominant-negative proteins or RNA interference to disrupt protein function or expression. The irreversibility of these methods and the time required for expression precludes their use in many experiments. The ideal technique will be highly specific, fast, and reversible, and act in an intact cell. Membrane-targeted molecular interference tools, such as specially designed peptides, come closer to meeting these criteria than several existing techniques. Covic et al. (2002)
designed palmitoylated peptides, termed "pepducins," that were directed against the third intracellular loop (one putative G-protein binding region) of GPCRs. These pepducins penetrated the cell membrane and activated G-proteins in the manner of the GPCRs they were based on.
The recent Journal of Neuroscience paper by Robbins et al. (2006)
introduced novel applications of this palmitoylated peptide approach. Their technique, modeled after the pepducins designed by Covic et al. (2002)
, used palmitoyl-tagged peptides (10-mer "palpeptides") that mimicked the binding site for the target molecule and were cell permeant. This method allowed the researchers to prevent activation of specific G-proteins or to sequester PIP2.
The Gq/11 palpeptide, which contained the receptor-binding region from the C terminus of G
q, effectively blocked coupling between the M1 muscarinic acetylcholine receptor (M1R) and downstream inhibition of both M current [Robbins et al., their Fig. 1 (http://www.jneurosci.org/cgi/content/full/26/30/7950/F1)] and calcium current. Gq/11 palpeptide action was dose dependent, fast, and G-protein subtype specific, because it did not interfere with calcium channel inhibition via Go-coupled adrenergic receptors [Robbins et al., their Fig. 2 (http://www.jneurosci.org/cgi/content/full/26/30/7950/F2)]. Likewise, the Go palpeptide selectively blocked norepinephrine (NE)-induced calcium current inhibition, but not inhibition by the muscarinic agonist oxotremorine-M (Oxo-M) [Robbins et al., their Fig. 3 (http://www.jneurosci.org/cgi/content/full/26/30/7950/F3)] acting via M1R. However, both G-protein palpeptides appear to have enhanced calcium channel inhibition nonspecifically. A scrambled version of the Go palpeptide substantially augmented NE-evoked inhibition relative to palpeptide-free controls [Robbins et al., their Figs. 2B (http://www.jneurosci.org/cgi/content/full/26/30/7950/F2) and 3A (http://www.jneurosci.org/cgi/content/full/26/30/7950/F3)]. The authors showed that palmitoyl tethering prevented a Shaker inactivation ball from blocking the pore of a Kv1.2 channel [Robbins et al., their Fig. 11 (http://www.jneurosci.org/cgi/content/full/26/30/7950/F11)] but did not rule out the possibility of G
palpeptide occlusion of calcium channels.
The second set of palpeptides was directed against PIP2, using a region of the Kv7.2 C terminus shown to be important in regulating channel affinity for PIP2. PIP2 palpeptide inhibition of M current was dose dependent, rapid, M1R independent, and specific because it only inhibited PIP2-independent potassium currents to a small extent. It was only slightly reversible on washout [Robbins et al., their Fig. 5 (http://www.jneurosci.org/cgi/content/full/26/30/7950/F5)]. The PIP2 palpeptide acted in a manner consistent with a reduction in the available pool of PIP2, because its inhibitory action on M current was rescued by addition of the PIP2 analog, diC8PIP2 [Robbins et al., their Fig. 8 (http://www.jneurosci.org/cgi/content/full/26/30/7950/F8)]. Furthermore, the PIP2 palpeptide enhanced M1R suppression of M current [Robbins et al., their Fig. 9 (http://www.jneurosci.org/cgi/content/full/26/30/7950/F9)]. Importantly, the authors found a loose relationship between the structure and function of PIP2 palpeptides; both a scrambled palpeptide and a palpeptide formed exclusively of lysine residues had higher affinities for PIP2 than the potential PIP2 binding sequence from Kv7.2 [Robbins et al., their Table 1 (http://www.jneurosci.org/cgi/content/full/26/30/7950/T1)]. This suggests either the absence of a highly conserved PIP2 binding domain, or the inability of the palpeptides to recreate the binding motif of Kv7.2. Sequence and functional analysis from many channels supports the former; electrostatic attraction to basic residues may constitute the mechanism of PIP2 binding. Palpeptides based on other channel domains could help to further characterize this mechanism.
Robbins and colleagues motivated their experiments by suggesting that membrane-targeted peptide probes could be used to delineate multiple contributions to regulation of M current. Their results suggest that PIP2 depletion accounts for >95% of M current inhibition [Robbins et al., their Fig. 5B,D (http://www.jneurosci.org/cgi/content/full/26/30/7950/F5)], making the maximal effect of PIP2 palpeptides virtually indistinguishable from that of saturating concentrations of Oxo-M. However, because PIP2 palpeptides may interfere with hydrolysis of bound PIP2, both release of calcium stores and activation of protein kinase C could be attenuated in their presence. Consequently, it remains difficult to rule out additional roles of other Gq/11 effectors such as calcium/calmodulin or protein kinase C.
Despite these caveats, Robbins et al. (2006)
have succeeded in developing a useful and exciting new tool to add to the molecular repertoire for studying GPCR signaling and its many manifestations. This technique may also prove to be useful in the design of new therapeutics that can specifically and rapidly target components of GPCR signaling pathways.
Received Aug. 18, 2006;
revised Aug. 25, 2006;
accepted Aug. 25, 2006.
Correspondence should be addressed to Jill B. Jensen, Department of Physiology and Biophysics, University of Washington School of Medicine, Seattle, WA 98195. Email: jbodily{at}u.washington.edu
Copyright © 2006 Society for Neuroscience 0270-6474/06/2610621-02$15.00/0
References
Caulfield MP, Jones S, Vallis Y, Buckley NJ, Kim GD, Milligan G, Brown DA (1994) Muscarinic M-current inhibition via G
q/11 and
-adrenoceptor inhibition of Ca2+ current via G
o in rat sympathetic neurones. J Physiol (Lond) 477:415422.[ISI][Medline]
Covic L, Gresser AL, Talavera J, Swift S, Kuliopulos A (2002) Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides. Proc Natl Acad Sci USA 99:643648.[Abstract/Free Full Text]
Robbins J, Marsh SJ, Brown DA (2006) Probing the regulation of M (Kv7) potassium channels in intact neurons with membrane-targeted peptides. J Neurosci 26:79507961.[Abstract/Free Full Text]
Suh BC, Hille B (2005) Regulation of ion channels by phosphatidylinositol 4,5-bisphosphate. Curr Opin Neurobiol 15:370378.[CrossRef][ISI][Medline]
Related articles in J. Neurosci.:
- Probing the Regulation of M (Kv7) Potassium Channels in Intact Neurons with Membrane-Targeted Peptides
- Jon Robbins, Stephen J. Marsh, and David A. Brown
J. Neurosci. 2006 26: 7950-7961.
[Abstract]
[Full Text]